Genetic Variation in Neisseria meningitidis Does Not Influence Disease Severity in Meningococcal Meningitis [PDF]
Frontiers in Medicine, 2020 Neisseria meningitidis causes sepsis and meningitis in humans. It has been suggested that pathogen genetic variation determines variance in disease severity. Here we report results of a genome-wide association study of 486 N.
Philip H. C. Kremer +9 more
doaj +3 more sources
PLoS ONE, 2015 BackgroundTo facilitate the interpretation of meningococcal meningitis epidemiology in the "African meningitis belt", we aimed at obtaining serogroup-specific pooled estimates of incidence, carriage and case-carrier ratios for meningococcal meningitis in
Thibaut Koutangni +2 more
doaj +4 more sources
Meningococcal purpura fulminans and severe myocarditis with clinical meningitis but no meningeal inflammation: a case report [PDF]
BMC Infectious Diseases, 2019 Background During fulminant meningococcal septicaemia, meningococci are often observed in the cerebrospinal fluid (CSF) although the patients have frequently no meningeal symptoms.
Mehdi Hage-Sleiman +8 more
doaj +3 more sources
A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
PLoS ONE, 2016 The pattern of epidemic meningococcal disease in the African meningitis belt may be influenced by the background level of population immunity but this has been measured infrequently.
Olivier Manigart +33 more
doaj +4 more sources
Cerebral Venous Sinus Thrombosis in a Patient with Meningococcal Meningitis [PDF]
Oman Medical Journal, 2018 Meningococcal meningitis has a wide range of neurological complications. However, cerebral venous sinus thrombosis (CVST) following infection with Neisseria meningitidis is uncommon.
Sudhir Kumar Palat Chirakkara1*, +3 more
doaj +3 more sources
Meningococcal meningitis and COVID-19 co-infection. [PDF]
BMJ Case Rep, 2020 Bacterial co-infection in the ongoing pandemic of COVID-19 is associated with poor outcomes but remains little understood. A 22-year-old woman presented with a 3-week history of fever, headache, neck stiffness, rigours and confusion.
Gallacher SD, Seaton A.
europepmc +2 more sources
Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis. [PDF]
PLoS One, 2018 Introduction In sub Saharan Africa, the epidemiology, including the distribution of serogroups of strains of N. meningitidis is poorly investigated in countries outside “the meningitis belt”.
Munguambe AM +7 more
europepmc +2 more sources
Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017. [PDF]
J Infect Dis, 2019 Background In 2010–2017, meningococcal serogroup A conjugate vaccine (MACV) was introduced in 21 African meningitis belt countries. Neisseria meningitidis A epidemics have been eliminated here; however, non-A serogroup epidemics continue.
Fernandez K +13 more
europepmc +2 more sources
Arquivos de Neuro-Psiquiatria, 2016 Meningococcal meningitis is a public health problem. The aim of this study was to describe the clinical characteristics of patients with meningococcal meningitis, and to identify associated factors with mortality.
Vanessa L. Strelow +5 more
doaj +2 more sources
Climate Regimes, El Nino-Southern Oscillation and Meningococcal Meningitis Epidemics
Frontiers in Public Health, 2015 Meningoccocal meningitis is a major public health problem that kills thousands annuallyin Africa, Europe, North and South America. Occurrence is, however, highest during thedry seasons in Sahel Africa.
Olusegun Steven Ayodele Oluwole
doaj +2 more sources